Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
35,258,614
-
Total 13F shares
-
4,420,722
-
Share change
-
+479,759
-
Total reported value
-
$17,152,699
-
Put/Call ratio
-
262%
-
Price per share
-
$3.88
-
Number of holders
-
55
-
Value change
-
+$1,892,994
-
Number of buys
-
18
-
Number of sells
-
17
Institutional Holders of Anixa Biosciences Inc - Common Stock (ANIX) as of Q4 2023
As of 31 Dec 2023,
Anixa Biosciences Inc - Common Stock (ANIX) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,420,722 shares.
The largest 10 holders included
VANGUARD GROUP INC, UBS Group AG, MISSION WEALTH MANAGEMENT, LP, LAIRD NORTON TRUST COMPANY, LLC, GEODE CAPITAL MANAGEMENT, LLC, Long Focus Capital Management, LLC, BlackRock Inc., STATE STREET CORP, Bank of New York Mellon Corp, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
55
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.